Skip to main content

Brain RGS4 and RGS10 protein expression in schizophrenia and depression. Effect of drug treatment

Psychopharmacology volume 226, pages 177–188 (2013)Cite this article

Abstract

Rationale

Regulator of G-protein signaling (RGS) proteins, RGS4 and RGS10, may be involved in the pathophysiology of schizophrenia. RGS4 has attracted special interest since the reports of genetic association between SNPs in RGS4 and schizophrenia. However, there is no information about the subcellular distribution of RGS4 and RGS10 proteins in psychiatric disorders.

Objectives

Plasma membrane RGS4 and cytosolic RGS10 protein immunoreactivity in prefrontal cortex from schizophrenic subjects (n = 25), non-diagnosed suicides (n = 13), and control subjects (n = 35), matched by age, gender, and postmortem delay, was analyzed by western blot. A second group of depressed subjects (n = 25) and control subjects (n = 25) was evaluated. The effect of the antipsychotic or antidepressant treatments was also assessed.

Results

No significant differences in plasma membrane RGS4 and cytosolic RGS10 protein expression were observed between schizophrenic subjects, non-diagnosed suicides, and control subjects. However, RGS4 immunoreactivity was significantly higher (Δ = 33 ± 10 %, p < 0.05) in the antipsychotic-treated subgroup (n = 12) than in the antipsychotic-free subgroup (n = 13). Immunodensities of plasma membrane RGS4 and cytosolic RGS10 proteins did not differ between depressed and matched control subjects.

Conclusions

Expression of RGS4 and RGS10 proteins at their predominant subcellular location was studied in the postmortem brain of subjects with psychiatric disorders. The results suggest unaltered membrane RGS4 and cytosolic RGS10 proteins levels in schizophrenia and major depression. Antipsychotic treatment seems to increase membrane RGS4 immunoreactivity. Further studies are needed to elucidate RGS4 and RGS10 functional status.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2

References

  • Abramow-Newerly M, Ming H, Chidiac P (2006) Modulation of subfamily B/R4 RGS protein function by 14-3-3 proteins. Cell Signal 18:2209–2222

    PubMed  Article  CAS  Google Scholar 

  • Beyer CE, Ghavami A, Lin Q, Sun A, Rhodes KJ, Dawson LA, Schechter LE, Young KH (2004) Regulators of G-protein signaling 4: modulation of 5-HT1A-mediated neurotransmitter release in vivo. Brain Res 1022:214–220

    PubMed  Article  CAS  Google Scholar 

  • Bowden NA, Scott RJ, Tooney PA (2007) Altered expression of regulator of G-protein signalling 4 (RGS4) mRNA in the superior temporal gyrus in schizophrenia. Schizophr Res 89:165–168

    PubMed  Article  Google Scholar 

  • Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254

    PubMed  Article  CAS  Google Scholar 

  • Brzustowicz LM, Hodgkinson KA, Chow EW, Honner WG, Bassett AS (2000) Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science 288:678–682

    PubMed  Article  CAS  Google Scholar 

  • Burgon PG, Lee WL, Nixon AB, Peralta EG, Casey PJ (2001) Phosphorylation and nuclear translocation of a regulator of G protein signaling (RGS10). J Biol Chem 276:32828–32834

    PubMed  Article  CAS  Google Scholar 

  • Capatano LA, Manji HK (2007) G protein-coupled receptors in major psychiatric disorders. Biochim Biophys Acta 1768:976–993

    Article  Google Scholar 

  • Chen X, Dunham C, Kendler S, Wang X, O’Neill FA, Walsh D, Kendler KS (2004) Regulator of G-protein signaling 4 (RGS4) gene is associated with schizophrenia in Irish high density families. Am J Med Genet Part B 129B:23–26

    PubMed  Article  Google Scholar 

  • Chowdari KV, Mirnics K, Semwal P, Wood J, Lawrence E, Bhatia T, Deshpande SN, Thelma BK, Ferrell RE, Middleton FA, Devlin B, Levitt P, Lewis DA, Nimgaonkar VL (2002) Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum Mol Genet 11:1373–1380

    PubMed  Article  CAS  Google Scholar 

  • Damjanoska KJ, Van de Kar LD, Kindel GH, Zhang Y, D’Souza DN, Garcia F, Battaglia G, Muma NA (2003) Chronic fluoxetine differentially affects 5-hydroxytryptamine2A receptor signaling in frontal cortex, oxytocin- and corticotropin-releasing factor-containing neurons in rat paraventricular nucleus. J Pharmacol Exp Ther 306:563–571

    PubMed  Article  CAS  Google Scholar 

  • Ding L, Hedge AN (2009) Expression of RGS4 splice variants in dorsolateral prefrontal cortex of schizophrenic and bipolar disorder patients. Biol Psychiatry 65:541–545

    PubMed  Article  CAS  Google Scholar 

  • Ding L, Mychaleckyj JC, Hegde AN (2007) Full length cloning and expression analysis of splice variants of regulator of G-protein signaling RGS4 in human and murine brain. Gene 401:46–60

    PubMed  Article  CAS  Google Scholar 

  • Erdely HA, Tamminga CA, Roberts RC, Vogel MW (2006) Regional alterations in RGS4 protein in schizophrenia. Synapse 59:472–479

    PubMed  Article  CAS  Google Scholar 

  • Ernst C, Mechawar N, Turecki G (2009) Suicide neurobiology. Prog Neurobiol 89:315–333

    PubMed  Article  CAS  Google Scholar 

  • Geurts M, Maloteaux JM, Hermans E (2003) Altered expression of regulators of G-protein signaling (RGS) mRNAs in the striatum of rats undergoing dopamine depletion. Biochem Pharmacol 66:1163–1170

    PubMed  Article  CAS  Google Scholar 

  • Ghavami A, Hunt RA, Olsen MA, Zhang J, Smith DL, Kalgaonkar S, Rahman Z, Young KH (2004) Differential effects of regulator of G protein signaling (RGS) proteins on serotonin 5-HT1A, 5-HT2A, and dopamine D2 receptor-mediated signaling and adenylyl cyclase activity. Cell Signal 16:711–721

    PubMed  Article  CAS  Google Scholar 

  • Gold SJ, Heifets BD, Pudiak CM, Potts BW, Nestler EJ (2002) Regulation of regulators of G protein signaling mRNA expression in rat brain by acute and chronic electroconvulsive seizures. J Neurochem 82:828–838

    PubMed  Article  CAS  Google Scholar 

  • Gold SJ, Han MH, Herman AE, Ni YG, Pudiak CM, Aghajanian GK, Liu RJ, Potts BW, Mumby SM, Nestler EJ (2003) Regulation of RGS proteins by chronic morphine in rat locus coeruleus. Eur J Neurosci 17:971–980

    PubMed  Article  Google Scholar 

  • Gu S, He J, Ho WT, Ramineni S, Thal DM, Natesh R, Tesmer JJ, Hepler JR, Heximer SP (2007) Unique hydrophobic extension of the RGS2 amphipathic helix domain imparts increased plasma membrane binding and function relative to other RGS R4/B subfamily members. J Biol Chem 282:33064–33075

    PubMed  Article  CAS  Google Scholar 

  • Guo S, Tang W, Shi Y, Huang K, Xi Z, Xu Y, Feng G, He L (2006) RGS4 polymorphisms and risk of schizophrenia: an association study in Han Chinese plus meta-analysis. Neurosci Lett 406:122–127

    PubMed  Article  CAS  Google Scholar 

  • Haller C, Fillatreau S, Hoffmann R, Agenes F (2002) Structure, chromosomal localization and expression of the mouse regulator of G-protein signaling10 gene (mRGS10). Gene 297:39–49

    PubMed  Article  CAS  Google Scholar 

  • Harrison PJ (1999) The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122(Pt 4):593–624

    PubMed  Article  Google Scholar 

  • Hishimoto A, Shirakawa O, Nishiguchi N, Aoyama S, Ono H, Hashimoto T, Maeda K (2004) Novel missense polymorphism in the regulator of G-protein signaling 10 gene: analysis of association with schizophrenia. Psychiatry Clin Neurosci 58:579–581

    PubMed  Article  CAS  Google Scholar 

  • Hollinger S, Hepler JR (2002) Cellular regulation of RGS proteins: modulators and integrators of G protein signaling. Pharmacol Rev 54:527–559

    PubMed  Article  CAS  Google Scholar 

  • Ishiguro H, Horiuchi Y, Koga M, Inada T, Iwata N, Ozaki N, Ujike H, Muratake T, Someya T, Arinami T (2007) RGS4 is not a susceptibility gene for schizophrenia in Japanese: association study in a large case–control population. Schizophr Res 89:161–164

    PubMed  Article  CAS  Google Scholar 

  • Joiner TE Jr, Brown JS, Wingate LR (2005) The psychology and neurobiology of suicidal behavior. Annu Rev Psychol 56:287–314

    PubMed  Article  Google Scholar 

  • Kampman O, Illi A, Hänninen K, Katila H, Anttila S, Rontu R, Mattila KM, Leinonen E, Lehtimäki T (2006) RGS4 genotype is not associated with antipsychotic medication response in schizophrenia. J Neural Transm 113:1563–1568

    PubMed  Article  CAS  Google Scholar 

  • Larminie C, Murdock P, Walhin JP, Duckworth M, Blumer KJ, Scheideler MA, Garnier M (2004) Selective expression of regulators of G-protein signaling (RGS) in the human central nervous system. Brain Res Mol Brain Res 122:24–34

    PubMed  Article  CAS  Google Scholar 

  • Levitt P, Ebert P, Mirnics K, Nimgaonkar VL, Lewis DA (2006) Making the case for a candidate vulnerability gene in schizophrenia: convergent evidence for regulator of G-protein signaling 4 (RGS4). Biol Psychiatry 60:534–537

    PubMed  Article  CAS  Google Scholar 

  • Lewis DA, Lieberman JA (2000) Catching up on schizophrenia: natural history and neurobiology. Neuron 28:325–334

    PubMed  Article  CAS  Google Scholar 

  • Li D, He L (2006) Association study of the G-protein signaling 4 (RGS4) and proline dehydrogenase (PRODH) genes with schizophrenia: a meta-analysis. Eur J Hum Genet 14:1130–1135

    PubMed  Article  CAS  Google Scholar 

  • Lipska BK, Mitkus S, Caruso M, Hyde TM, Chen J, Vakkalanka R, Straub RE, Weinberger DR, Kleinman JE (2006) RGS4 mRNA expression in postmortem human cortex is associated with COMT Val158Met genotype and COMT enzyme activity. Hum Mol Genet 15:2804–2812

    PubMed  Article  CAS  Google Scholar 

  • Liu Y-L, Shen-Jang Fann C, Liu CM, Wu JY, Hung SI, Chan HY, Chen JJ, Lin CY, Liu SK, Hsieh MH, Hwang TJ, Ouyang WC, Chen CY, Lin JJ, Chou FH, Chueh CM, Liu WM, Tsuang MM, Faraone SV, Tsuang MT, Chen WJ, Hwu HG (2006) Evaluation of RGS4 as a candidate gene for schizophrenia. Am J Med Genet Part B 141B:418–420

    PubMed  Article  CAS  Google Scholar 

  • Min C, Cheong S-Y, Cheong S-J, Kim M, Cho D-I, Kim K-M (2012) RGS4 exerts inhibitory activities on the signaling of dopamine D2 receptor and D3 receptor through the N-terminal region. Pharmacol Res 65:213–220

    PubMed  Article  CAS  Google Scholar 

  • Mirnics K, Middleton FA, Stanwood GD, Lewis DA, Levitt P (2001) Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol Psychiatry 6:293–301

    PubMed  Article  CAS  Google Scholar 

  • Morris DW, Rodgers A, McGhee KA, Schwaiger S, Scully P, Quinn J, Meagher D, Waddington JL, Gill M, Corvin AP (2004) Confirming RGS4 as a susceptibility gene for schizophrenia. Am J Med Genet Part B 125B:50–53

    PubMed  Article  Google Scholar 

  • Muma NA, Mariyappa R, Williams K, Lee JM (2003) Differences in regional and subcellular localization of G(q/11) and RGS4 protein levels in Alzheimer's disease: correlation with muscarinic M1 receptor binding parameters. Synapse 47:58–65

    PubMed  Article  CAS  Google Scholar 

  • Muma NA, Singh RK, Vercillo MS, D’Souza DN, Zemaitaitis B, Garcia F, Damjanoska KJ, Zhang Y, Battaglia G, Van de Kar LD (2007) Chronic olanzapine activates the Stat3 signal transduction pathway and alters expression of components of the 5-HT2A receptor signaling system in rat frontal cortex. Neuropharmacology 53:552–562

    PubMed  Article  CAS  Google Scholar 

  • Ni YG, Gold SJ, Iredale PA, Terwilliger RZ, Duman RS, Nestler EJ (1999) Region-specific regulation of RGS4 (regulator of G-protein-signaling protein type 4) in brain by stress and glucocorticoids: in vivo and in vitro studies. J Neurosci 19:3674–3680

    PubMed  CAS  Google Scholar 

  • Popov S, Yu K, Kozasa T, Wilkie TM (1997) The regulators of G protein signaling (RGS) domains of RGS4, RGS10, and GAIP retain GTPase activating protein activity in vitro. Proc Natl Acad Sci U S A 94:7216–7220

    PubMed  Article  CAS  Google Scholar 

  • Rajkowska G, Goldman-Rakic PS (1995) Cytoarchitectonic definition of prefrontal areas in the normal human cortex: I. Remapping of areas 9 and 46 using quantitative criteria. Cereb Cortex 5:307–322

    PubMed  Article  CAS  Google Scholar 

  • Réthelyi JM, Bakker SC, Polgar P, Czobor P, Strengman E, Pásztor PI, Kahn RS, Bitter I (2009) Association study of NGR1, DTNBP1, RGS4, G72/G30, and PIP5K2A with schizophrenia and symptom severity in a Hungarian sample. Am J Med Genet Part B 153B:792–801

    Google Scholar 

  • Rimler A, Jockers R, Lupowitz Z, Sampson SR, Zisapel N (2006) Differential effects of melatonin and its downstream effector PKCα on subcellular localization of RGS proteins. J Pineal Res 40:144–152

    PubMed  Article  CAS  Google Scholar 

  • Rivero G, Gabilondo AM, García-Sevilla JA, La Harpe R, Morentín B, Meana JJ (2010) Characterization of regulators of G-protein signaling RGS4 and RGS10 proteins in the postmortem human brain. Neurochem Int 57:722–729

    PubMed  Article  CAS  Google Scholar 

  • Rizig MA, McQuillin A, Puri V, Choudhury K, Datta S, Thirumalai S, Lawrence J, Quested D, Pimm J, Bass N, Lamb G, Moorey H, Badacsonyi A, Kelly K, Morgan J, Punukollu B, Kandasami G, Curtis D, Gurling H (2006) Failure to confirm genetic association between schizophrenia and markers on chromosome 1q23.3 in the region of the gene encoding the regulator of G-protein signaling 4 protein (RGS4). Am J Med Genet Part B 141B:296–300

    PubMed  Article  CAS  Google Scholar 

  • Saugstad JA, Marino MJ, Folk JA, Hepler JR, Conn PJ (1998) RGS4 inhibits signaling by group I metabotropic glutamate receptors. J Neurosci 18:905–913

    PubMed  CAS  Google Scholar 

  • Schwendt M, Gold SJ, McGinty JF (2006) Acute amphetamine down-regulates RGS4 mRNA and protein expression in rat forebrain: distinct roles of D1 and D2 dopamine receptors. J Neurochem 96:1606–1615

    PubMed  Article  CAS  Google Scholar 

  • Shi J, Damjanoska KJ, Zemaitaitis B, Garcia F, Carrasco G, Sullivan NR, She Y, Young KH, Battaglia G, Van De Kar LD, Howland DS, Muma NA (2006) Alterations in 5-HT2A receptor signaling in male and female transgenic rats over-expressing either Gq or RGS-insensitive Gq protein. Neuropharmacology 51:524–535

    PubMed  Article  CAS  Google Scholar 

  • Sobell JL, Richard C, Wirshing DA, Heston LL (2005) Failure to confirm association between RGS4 haplotypes and schizophrenia in Caucasians. Am J Med Genet Part B 139B:23–27

    PubMed  Article  CAS  Google Scholar 

  • Stuart-Gibbons A, Scarr E, McOmish CE, Hannan AJ, Thomas EA, Dean B (2008) Regulator of G-protein signalling 4 expression is not altered in the prefrontal cortex in schizophrenia. Aust N Z J Psychiatry 42:740–745

    PubMed  Article  Google Scholar 

  • Talkowski ME, Chowdari K, Lewis DA, Nimgaonkar VL (2006a) Can RGS4 polymorphisms be viewed as credible risk factors for schizophrenia? A critical review of the evidence. Schizophr Bull 32:203–208

    PubMed  Article  Google Scholar 

  • Talkowski ME, Seltman H, Bassett AS, Brzustowicz LM, Chen X, Chowdari KV, Collier DA, Cordeiro Q, Corvin AP, Deshpande SN, Egan MF, Gill M, Kendler KS, Kirov G, Heston LL, Levitt P, Lewis DA, Li T, Mirnics K, Morris DW, Norton N, O’Donovan MC, Owen MJ, Richard C, Semwal P, Sobell JL, St Clair D, Straub RE, Thelma BK, Vallada H, Weinberger DR, Williams NM, Wood J, Zhang F, Devlin B, Nimgaonkar VL (2006b) Evaluation of a susceptibility gene for schizophrenia: genotype based meta-analysis of RGS4 polymorphisms from thirteen independent samples. Biol Psychiatry 60:152–162

    PubMed  Article  CAS  Google Scholar 

  • Thaker GK, Carpenter WT Jr (2001) Advances in schizophrenia. Nat Med 7:667–671

    PubMed  Article  CAS  Google Scholar 

  • Tu Y, Woodson J, Ross EM (2001) Binding of regulator of G protein signaling (RGS) proteins to phospholipid bilayers. Contribution of location and/or orientation to GTPase-activating protein activity. J Biol Chem 276:20160–20166

    PubMed  Article  CAS  Google Scholar 

  • Vilella E, Costas J, Sanjuan J, Guitart M, De Diego Y, Carracedo A, Martorell L, Valero J, Labad A, De Frutos R, Nájera C, Moltó MD, Toirac I, Guillamat R, Brunet A, Vallès V, Pérez L, Leon M, de Fonseca FR, Phillips C, Torres M (2008) Association of schizophrenia with DTNBP1 buy not with DAO, DAOA, NGR1 and RGS4 nor their genetic interaction. J Psychiatr Res 42:278–288

    PubMed  Article  Google Scholar 

  • Volk DW, Egan SM, Lewis DA (2010) Alterations in metabotropic glutamate receptor 1α and regulator of G protein signaling 4 in the prefrontal cortex in schizophrenia. Am J Psychiatry 167:1489–1498

    PubMed  Article  Google Scholar 

  • Wang Q, Traynor JR (2011) Opioid-induced down-regulation of RGS4: role of ubiquitination and implications for receptor cross-talk. J Biol Chem 286:7854–7864

    PubMed  Article  CAS  Google Scholar 

  • Williams NM, Preece A, Spurlock G, Norton N, Williams HJ, McCreadie RG, Buckland P, Sharkey V, Chowdari KV, Zammit S, Nimgaonkar V, Kirov G, Owen MJ, O’Donovan MC (2004) Support for RGS4 as a susceptibility gene for schizophrenia. Biol Psychiatry 55:192–195

    PubMed  Article  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by grants from MINECO-FEDER (SAF2009-08460), Basque Government (IT-199/07), and UPV/EHU to J.J.M., and from SAF2011-29918 to J.A.G.S. G.R. was supported by a fellowship from the Basque Government. The authors wish to thank the staff members of the Basque Institute of Legal Medicine, Bilbao, and the Romand University Center of Legal Medicine, Geneva, for their cooperation in the study and Dr. Javier Ballesteros from the Department of Neurosciences, University of the Basque Country UPV/EHU for the useful statistical assistance.

Conflicts of interest

The authors declare no conflict of interest.

Author information

Author notes

  1. G. Rivero

    Present address: Omnia Molecular Ltd., Barcelona Science Park, 08028, Barcelona, Spain

Affiliations

  1. Department of Pharmacology, BioCruces Health Research Institute, University of the Basque Country UPV/EHU and Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), 48940, Leioa, Bizkaia, Spain

    G. Rivero, A. M. Gabilondo, L. F. Callado & J. J. Meana

  2. Laboratory of Neuropharmacology, IUNICS and Red Temática de Investigación Cooperativa en Salud (RETICS-Trastornos Adictivos), University of the Balearic Islands, 07122, Palma de Mallorca, Spain

    J. A. García-Sevilla

  3. Centre Universitaire Romand de Médecine Légale-Site Genève, Faculté de Médecine, Université de Genève, 1211, Genève 4, Switzerland

    R. La Harpe

  4. Basque Institute of Legal Medicine, 48001, Bilbao, Spain

    B. Morentin

Authors
  1. G. Rivero
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. M. Gabilondo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. A. García-Sevilla
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. F. Callado
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. La Harpe
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. B. Morentin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J. J. Meana
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. M. Gabilondo.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Rivero, G., Gabilondo, A.M., García-Sevilla, J.A. et al. Brain RGS4 and RGS10 protein expression in schizophrenia and depression. Effect of drug treatment. Psychopharmacology 226, 177–188 (2013). https://doi.org/10.1007/s00213-012-2888-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-012-2888-5

Keywords

  • Prefrontal cortex
  • RGS4
  • RGS10
  • Schizophrenia
  • Major depression
  • Intracellular signaling